NCT07156539: A Phase 3 Study of HS-20094 in Patients With T2DM
- State
- Not started
- Phase
- Phase 3
- People
- 546 planned
- Started
- 30 Sep 2025
- Primary completion
- 30 Mar 2027
- Arms
- Treatment Group A, Treatment Group B
- Results
- None posted
- 5 Sep 2025: Trial registered